After adjustment for family history, tumor histology and tumor grade, patients affected by TNBC showed a 323 % higher risk of BRCA1 mutations than non-TNBC patients (RP = 4.23; 95 % CI 2.50–7.14; P < 0.0001). The gene discussed is BRCA1; the disease is neoplasm.